Skip to main content
. 2019 Sep 30;55(6):1296–1312. doi: 10.3892/ijo.2019.4887

Figure 3.

Figure 3

Anisomycin inhibits proliferation of CD44+/CD133+ HuOCSCs. (A) Proliferation of HuOCSCs, treated as indicated, was evaluated with the MTT assay. (B) Quantification and (C) representative plots from Annexin V/PI staining and flow cytometry analysis of HuOCSCs, treated as indicated. **P<0.01 vs. non-treated cells (n=4). HuOCSCs, human ovarian cancer stem cells.